In the db/db mouse model of NAFLD, the deletion of E2f1 prevents lipid accumulation in the liver, which may be related to the improvement in hepatic metabolic homeostasis by E2F1 through the control of glucose and lipid production pathways [43,44]. This evidence concerns the gene E2F1 and metabolic dysfunction-associated steatotic liver disease.